Llewelyn Linda 4

What Happened

• Linda Llewelyn, Chief People Officer of Health Catalyst (HCAT), was granted a total of 204,695 equity units on Feb 25, 2026: 191,500 restricted stock units (RSUs) and 13,195 performance-based RSUs (PRSUs). Both awards were granted at no cash cost (price reported $0.00).
• On Feb 26, 2026, 4,471 shares were disposed at $1.75 per share (proceeds ≈ $7,814). That sale was a mandatory "sell to cover" to satisfy tax-withholding obligations tied to the RSU vesting, not a discretionary open-market sale.

Key Details

• Transaction dates: Grants on 2026-02-25; sell-to-cover on 2026-02-26. Form 4 filed 2026-02-27 (appears timely).
• Award amounts: 191,500 RSUs (F1) + 13,195 PRSUs (F2) = 204,695 units granted. Grant price: $0.00.
• Sale: 4,471 shares at $1.75 each; proceeds ≈ $7,814. Classified as tax withholding (F3), not a voluntary sale.
• Vesting: RSUs vest in 12 equal quarterly installments beginning March 1, 2026 (per F1). PRSUs vest based on performance for fiscal year ended Dec 31, 2025 (per F2).
• Shares owned after the transaction: not reported in the information provided.
• Filing/accession: Period of report 2026-02-25; Accession No. 0001780878-26-000001.

Context

• RSUs and PRSUs are contingent awards that convert into shares only if vesting conditions are met; grants themselves are not purchases and do not represent an immediate cash investment by the insider.
• The small sale was mandated by the company’s sell-to-cover tax withholding policy (common practice) and should not be interpreted as a discretionary signal of sentiment.